-
1
-
-
0032217267
-
IkappaB-NF-kappaB structures: At the interface of inflammation control
-
Baeuerle PA (1998). IkappaB-NF-kappaB structures: at the interface of inflammation control. Cell 11: 729-731.
-
(1998)
Cell
, vol.11
, pp. 729-731
-
-
Baeuerle, P.A.1
-
2
-
-
0033060260
-
Potential role of cholecystokinin in the development of acute pancreatitis
-
Beglinger C (1999). Potential role of cholecystokinin in the development of acute pancreatitis. Digestion 60 (Suppl 1): 61-63.
-
(1999)
Digestion
, vol.60
, Issue.SUPPL. 1
, pp. 61-63
-
-
Beglinger, C.1
-
3
-
-
27644515221
-
Advanced qRT-PCR technology allows detection of the cholecystokinin 1 receptor (CCK1R) expression in human pancreas
-
Galindo J, Jones N, Powell GL, Hollingsworth SJ, Shankley N (2005). Advanced qRT-PCR technology allows detection of the cholecystokinin 1 receptor (CCK1R) expression in human pancreas. Pancreas 31: 325-331.
-
(2005)
Pancreas
, vol.31
, pp. 325-331
-
-
Galindo, J.1
Jones, N.2
Powell, G.L.3
Hollingsworth, S.J.4
Shankley, N.5
-
4
-
-
0032246276
-
Early NF-kappaB activation is associated with hormone-induced pancreatitis
-
Gukovsky I, Gukovskaya AS, Blinman TA, Zaninovic V, Pandol SJ (1998). Early NF-kappaB activation is associated with hormone-induced pancreatitis. Am J Physiol 275: G1402-G1414.
-
(1998)
Am J Physiol
, vol.275
-
-
Gukovsky, I.1
Gukovskaya, A.S.2
Blinman, T.A.3
Zaninovic, V.4
Pandol, S.J.5
-
5
-
-
0032805832
-
Cholecystokinin induction of mob-1 chemokine expression in pancreatic acinar cells requires NF-kappaB activation
-
Han B, Logsdon CD (1999). Cholecystokinin induction of mob-1 chemokine expression in pancreatic acinar cells requires NF-kappaB activation. Am J Physiol 277: C74-C82.
-
(1999)
Am J Physiol
, vol.277
-
-
Han, B.1
Logsdon, C.D.2
-
6
-
-
35548948991
-
Design of concise, scalable route to a cholecystokinin 1 (CCK 1) receptor antagonist
-
Liang JT, Mani NS, Jones TK (2007). Design of concise, scalable route to a cholecystokinin 1 (CCK 1) receptor antagonist. J Org Chem 72: 8243-8250.
-
(2007)
J Org Chem
, vol.72
, pp. 8243-8250
-
-
Liang, J.T.1
Mani, N.S.2
Jones, T.K.3
-
7
-
-
0024506160
-
The role of cis-acting promoter elements in tissue-specific albumin gene expression
-
Maire P, Wuarin J, Schibler U (1989). The role of cis-acting promoter elements in tissue-specific albumin gene expression. Science 244: 343-346.
-
(1989)
Science
, vol.244
, pp. 343-346
-
-
Maire, P.1
Wuarin, J.2
Schibler, U.3
-
8
-
-
35548998776
-
JNJ-17156516 (3-[5-(3,4-dichloro-phenyl)-1-(4-methoxy-phenyl)- 1H-pyrazol-3-yl]-2-m-tolyl-propionate) a novel, potent and selective CCK1 receptor antagonist. In vitro and in vivo pharmacological comparison with dexloxiglumide
-
Morton MF, Barrett TD, Yan W, Freedman JM, Lagaud G, Prendergast CE et al. (2007). JNJ-17156516 (3-[5-(3,4-dichloro-phenyl)-1-(4-methoxy-phenyl)- 1H-pyrazol-3-yl]-2-m-tolyl-propionate) a novel, potent and selective CCK1 receptor antagonist. In vitro and in vivo pharmacological comparison with dexloxiglumide. J Pharmacol Exp Ther 323: 562-569.
-
(2007)
J Pharmacol Exp Ther
, vol.323
, pp. 562-569
-
-
Morton, M.F.1
Barrett, T.D.2
Yan, W.3
Freedman, J.M.4
Lagaud, G.5
Prendergast, C.E.6
-
9
-
-
0022098518
-
Effects of proglumide on ductal and basolateral secretion of pancreatic digestive enzymes
-
Niederau C, Grendell JH, Rothman SS (1985). Effects of proglumide on ductal and basolateral secretion of pancreatic digestive enzymes. Am J Physiol 249: G100-G107.
-
(1985)
Am J Physiol
, vol.249
-
-
Niederau, C.1
Grendell, J.H.2
Rothman, S.S.3
-
10
-
-
0023025329
-
Beneficial effects of cholecystokinin-receptor blockade and inhibition of proteolytic enzyme activity in experimental acute hemorrhagic pancreatitis in mice. Evidence for cholecystokinin as a major factor in the development of acute pancreatitis
-
Niederau C, Liddle RA, Ferrell LD, Grendell JH (1986). Beneficial effects of cholecystokinin-receptor blockade and inhibition of proteolytic enzyme activity in experimental acute hemorrhagic pancreatitis in mice. Evidence for cholecystokinin as a major factor in the development of acute pancreatitis. J Clin Invest 78: 1056-1063.
-
(1986)
J Clin Invest
, vol.78
, pp. 1056-1063
-
-
Niederau, C.1
Liddle, R.A.2
Ferrell, L.D.3
Grendell, J.H.4
-
11
-
-
0033055734
-
Clinical evaluation of cholecystokinin-A-receptor antagonist (loxiglumide) for the treatment of acute pancreatitis. A preliminary clinical trial. Study Group of Loxiglumide in Japan
-
Ochi K, Harada H, Satake K (1999). Clinical evaluation of cholecystokinin-A-receptor antagonist (loxiglumide) for the treatment of acute pancreatitis. A preliminary clinical trial. Study Group of Loxiglumide in Japan. Digestion 60 (Suppl 1): 81-85.
-
(1999)
Digestion
, vol.60
, Issue.SUPPL. 1
, pp. 81-85
-
-
Ochi, K.1
Harada, H.2
Satake, K.3
-
12
-
-
0033900819
-
Acute taurodeoxycholate-induced pancreatitis in the rat is associated with hyperCCKemia
-
Ohlsson B, Axelson J, Stenram U, Rehfeld JF, Ihse I (2000). Acute taurodeoxycholate-induced pancreatitis in the rat is associated with hyperCCKemia. Int J Pancreatol 27: 195-201.
-
(2000)
Int J Pancreatol
, vol.27
, pp. 195-201
-
-
Ohlsson, B.1
Axelson, J.2
Stenram, U.3
Rehfeld, J.F.4
Ihse, I.5
-
13
-
-
0034075546
-
Pathophysiological role of cholecystokinin in humans
-
Otsuki M (2000). Pathophysiological role of cholecystokinin in humans. J Gastroenterol Hepatol 15: D71-D83.
-
(2000)
J Gastroenterol Hepatol
, vol.15
-
-
Otsuki, M.1
-
14
-
-
4444354589
-
New insights into neurohormonal regulation of pancreatic secretion
-
Owyang C, Logsdon CD (2004). New insights into neurohormonal regulation of pancreatic secretion. Gastroenterology 127: 957-969.
-
(2004)
Gastroenterology
, vol.127
, pp. 957-969
-
-
Owyang, C.1
Logsdon, C.D.2
-
15
-
-
0036251597
-
Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males
-
Persiani S, D'Amato M, Makovec F, Tavares IA, Bishai PM, Rovati LC (2002). Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males. Int J Clin Pharmacol Ther 40: 198-206.
-
(2002)
Int J Clin Pharmacol Ther
, vol.40
, pp. 198-206
-
-
Persiani, S.1
D'Amato, M.2
Makovec, F.3
Tavares, I.A.4
Bishai, P.M.5
Rovati, L.C.6
-
16
-
-
0033056955
-
Therapeutic effects of loxiglumide on experimental acute pancreatitis using various models
-
Satake K, Kimura K, Saito T (1999). Therapeutic effects of loxiglumide on experimental acute pancreatitis using various models. Digestion 60 (Suppl 1): 64-68.
-
(1999)
Digestion
, vol.60
, Issue.SUPPL. 1
, pp. 64-68
-
-
Satake, K.1
Kimura, K.2
Saito, T.3
-
17
-
-
4444260453
-
PKC-delta and -epsilon regulate NF-kappaB activation induced by cholecystokinin and TNF-alpha in pancreatic acinar cells
-
Satoh A, Gukovskaya AS, Nieto JM, Cheng JH, Gukovsky I, Reeve Jr JR et al. (2004). PKC-delta and -epsilon regulate NF-kappaB activation induced by cholecystokinin and TNF-alpha in pancreatic acinar cells. Am J Physiol Gastrointest Liver Physiol 287: G582-G591.
-
(2004)
Am J Physiol Gastrointest Liver Physiol
, vol.287
-
-
Satoh, A.1
Gukovskaya, A.S.2
Nieto, J.M.3
Cheng, J.H.4
Gukovsky, I.5
Reeve Jr, J.R.6
-
18
-
-
18744389156
-
-
Shiratori K, Takeuchi T, Satake K, Matsuno S, Study Group of Loxiglumide in Japan (2002). Clinical evaluation of oral administration of a cholecystokinin-A receptor antagonist (loxiglumide) to patients with acute, painful attacks of chronic pancreatitis: a multicenter dose-response study in Japan. Pancreas 25: e1-e5.
-
Shiratori K, Takeuchi T, Satake K, Matsuno S, Study Group of Loxiglumide in Japan (2002). Clinical evaluation of oral administration of a cholecystokinin-A receptor antagonist (loxiglumide) to patients with acute, painful attacks of chronic pancreatitis: a multicenter dose-response study in Japan. Pancreas 25: e1-e5.
-
-
-
-
19
-
-
0030937508
-
Plasma cholecystokinin levels in acute pancreatitis
-
Shirohara H, Otsuki M (1997). Plasma cholecystokinin levels in acute pancreatitis. Pancreas 14: 249-254.
-
(1997)
Pancreas
, vol.14
, pp. 249-254
-
-
Shirohara, H.1
Otsuki, M.2
-
20
-
-
0027491238
-
Octreotide and cholecystokinin antagonist reduce edema in obstruction-induced acute pancreatitis
-
Toriumi Y, Samuel I, Wilcockson DP, Turkelson CM, Solomon TE, Joehl RJ (1993). Octreotide and cholecystokinin antagonist reduce edema in obstruction-induced acute pancreatitis. J Lab Clin Med 112: 450-454.
-
(1993)
J Lab Clin Med
, vol.112
, pp. 450-454
-
-
Toriumi, Y.1
Samuel, I.2
Wilcockson, D.P.3
Turkelson, C.M.4
Solomon, T.E.5
Joehl, R.J.6
-
21
-
-
3142752464
-
Disorders of the pancreas
-
Braunwald E, Fauci AS, Kasper DL et al, eds, McGraw-Hill: New York, NY. pp
-
Toskes PP, Greenberger NJ (2001). Disorders of the pancreas. In: Braunwald E, Fauci AS, Kasper DL et al. (eds). Harrison's 15th Edition. Principles of Internal Medicine. McGraw-Hill: New York, NY. pp 1788-1804.
-
(2001)
Harrison's 15th Edition. Principles of Internal Medicine
, pp. 1788-1804
-
-
Toskes, P.P.1
Greenberger, N.J.2
-
22
-
-
0028845124
-
Cholecystokinin receptors
-
Wank SA (1995). Cholecystokinin receptors. Am J Physiol 269: G628-G646.
-
(1995)
Am J Physiol
, vol.269
-
-
Wank, S.A.1
|